7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Acasti Pharma Inc
(NASDAQ:ACST) 

ACST stock logo

Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patie...

Founded: 2002
Full Time Employees: 32
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
Acasti Pharma Days Payable Outstanding ttm (DPO)
202201 202202 202203 202204 202205 202206 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 03.717.4111.1214.8218.5322.2425.94Thousand
Acasti Pharma Days Receivable Outstanding ttm (DSO)
202202 202203 202204 202205 202206 202207 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -10.9410.6832.353.9175.5397.15118.77140.38Thousand
Acasti Pharma Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.25-1.93-1.61-1.29-0.96-0.64-0.320
Acasti Pharma Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -2.25-1.93-1.61-1.29-0.96-0.64-0.320
Acasti Pharma Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.511.021.532.042.553.063.58
Acasti Pharma P/S ratio ttm
202202 202203 202204 202205 202206 202207 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -1,008.97-729.37-449.77-170.18109.42389.02668.61948.21
Acasti Pharma (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -3.24-2.78-2.31-1.85-1.39-0.93-0.460
Acasti Pharma P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 00.230.460.680.911.141.371.6
No extra charts and metrics for this ticker.